D. Boral Capital Reiterates Buy Rating for NRx Pharmaceuticals (NASDAQ:NRXP)
D. Boral Capital restated their buy rating on shares of NRx Pharmaceuticals (NASDAQ:NRXP – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. They currently have a $31.00 target price on the stock. A number of other equities analysts have also recently commented on NRXP. HC Wainwright reiterated a “buy” rating […]
D. Boral Capital restated their buy rating on shares of NRx Pharmaceuticals (NASDAQ:NRXP – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. They currently have a $31.00 target price on the stock. A number of other equities analysts have also recently commented on NRXP. HC Wainwright reiterated a “buy” rating […]
